NEW YORK — Two treatments that don't involve antibiotics have moved from the laboratory into clinical testing for control of nontuberculous mycobacteria (NTM) pulmonary disease, according to separate ...
Non-tuberculous mycobacterium (NTM), a serious lung disease, can be identified in different ways in patients. Recently, 2 studies evaluated specific identification and causes of NTM in order to help ...
The first European study into the burden of non-tuberculosis mycobacterium pulmonary disease (NTM-PD), published today in the European Respiratory Journal, has revealed that both the 3-year all-cause ...
BEDMINSTER, N.J., Feb. 01, 2016 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc.(OTCQB:MTNB), a clinical-stage biopharmaceutical company focused on identifying and developing safe and effective ...
Mycobacteriaceae represent a family of bacteria. This family includes several bacterial species, some of which cause human disease, and others which do not. Mycobacterium tuberculosis leads to the ...
NTMs are closely related to tuberculosis bacteria and can (but do not need to) cause infectious diseases in humans. They are called "nontuberculous mycobacteria" (NTMs) to distinguish them from ...
Please provide your email address to receive an email when new articles are posted on . Nontuberculous mycobacteria, or NTM, also called mycobacteria other than tuberculosis, traditionally have been ...
The CRISPR-based assay works by measuring MAC cell-free DNA (MAC-cfDNA) levels within patient blood samples. The test can yield results in as little as two hours, and the published preliminary ...
An 87-year-old man presents to Okinawa National Hospital in Japan following referral for evaluation of an abnormal shadow on the left lower lobe of his lung. This was detected in December 2016, during ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results